Journal article icon

Journal article

Assessment of chimpanzee adenovirus serotype 63 neutralizing antibodies prior to evaluation of a candidate malaria vaccine regimen based on viral vectors.

Abstract:
Prior to a chimpanzee adenovirus-based (ChAd63) malarial vaccine trial, sera were collected to assess ChAd63-specific neutralizing antibody titers in Banfora (Burkina Faso). The low neutralizing antibody titers reported in both adults and children (median titers, 139.1 and 35.0, respectively) are encouraging for the potential use of ChAd63 as a malarial vaccine vector.
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1128/CVI.00723-13

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Jenner Institute
Role:
Author
Expand authors...
Journal:
Clinical and vaccine immunology : CVI
Volume:
21
Issue:
6
Pages:
901-903
Publication date:
2014-06-01
DOI:
EISSN:
1556-679X
ISSN:
1556-6811
Source identifiers:
466051
Language:
English
Keywords:
Pubs id:
pubs:466051
UUID:
uuid:39b38a07-c8ce-4590-b48a-bccec493015f
Local pid:
pubs:466051
Deposit date:
2014-08-27

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP